Digenome-Seq

Digenome-Seq

In vitro Cas9-digested whole-genome sequencing to profile genome-wide Cas9 off-target effects (Digenome-seq). A multiplexed version has also been published. It belongs to a family of methods such as HTGTS, LAM-HTGTS, and Guide-seq that are aimed at detecting off-target effects of CRISPR/Cas9 and other RNA-guided engineered nucleases (RGENs).

This method detects off-target mutations induced by RGENs in a bulk population of cells by sequencing in vitro nuclease-digested genomes (digenomes). These digests should produce many DNA fragments with identical 5′ ends, which give rise to sequence reads that are vertically aligned at cleavage sites.

Pros:
  • Relies on DNA cleavage rather than binding
  • Performed in a genomic context and sites with a DNA/RNA bulge are captured
  • Off-targets can be detected with a frequency of 0.1% or lower1
Cons:
  • Requires in vivo cleavage confirmation
  • High skill requirement for bioinformatic analysis2